AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION

The paper focuses on the justification for preferential administration of antihypertensive combination therapy. Pharmacotherapeutic features of starting the treatment with a combination of angiotensin-converting enzyme inhibitors (ACEI) and calcium antagonists (AC) are reviewed. The authors also pre...

Full description

Bibliographic Details
Main Authors: L. L. Kirichenko, S. V. Gatsura, A. N. Golosova, K. V. Ovsyannikov, O. V. Budik, A. V. Fedorov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2014-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/12
id doaj-a8df74686148437dbd8d8840f940029b
record_format Article
spelling doaj-a8df74686148437dbd8d8840f940029b2021-07-28T13:50:57Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252014-02-01131646810.15829/1728-8800-2014-1-64-6812AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSIONL. L. Kirichenko0S. V. Gatsura1A. N. Golosova2K. V. Ovsyannikov3O. V. Budik4A. V. Fedorov5A.I. Evdokimov Moscow State Medico-Stomatological UniversityA.I. Evdokimov Moscow State Medico-Stomatological UniversityA.I. Evdokimov Moscow State Medico-Stomatological UniversityA.I. Evdokimov Moscow State Medico-Stomatological UniversityA.I. Evdokimov Moscow State Medico-Stomatological UniversityCentral Clinical Hospital, Russian Federal Customs Service, MoscowThe paper focuses on the justification for preferential administration of antihypertensive combination therapy. Pharmacotherapeutic features of starting the treatment with a combination of angiotensin-converting enzyme inhibitors (ACEI) and calcium antagonists (AC) are reviewed. The authors also present the latest evidence on the ACEI/AC combination effects on such vascular parameters as microcirculation and endothelial dysfunction.https://cardiovascular.elpub.ru/jour/article/view/12arterial hypertensionantihypertensive combination therapycalcium antagonistsangiotensin-converting enzyme inhibitorsmicrocirculationendothelial dysfunction
collection DOAJ
language Russian
format Article
sources DOAJ
author L. L. Kirichenko
S. V. Gatsura
A. N. Golosova
K. V. Ovsyannikov
O. V. Budik
A. V. Fedorov
spellingShingle L. L. Kirichenko
S. V. Gatsura
A. N. Golosova
K. V. Ovsyannikov
O. V. Budik
A. V. Fedorov
AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
Кардиоваскулярная терапия и профилактика
arterial hypertension
antihypertensive combination therapy
calcium antagonists
angiotensin-converting enzyme inhibitors
microcirculation
endothelial dysfunction
author_facet L. L. Kirichenko
S. V. Gatsura
A. N. Golosova
K. V. Ovsyannikov
O. V. Budik
A. V. Fedorov
author_sort L. L. Kirichenko
title AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
title_short AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
title_full AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
title_fullStr AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
title_full_unstemmed AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
title_sort angiotensin-converting enzyme inhibitor and calcium antagonist combination in pharmacotherapy of arterial hypertension
publisher «SILICEA-POLIGRAF» LLC
series Кардиоваскулярная терапия и профилактика
issn 1728-8800
2619-0125
publishDate 2014-02-01
description The paper focuses on the justification for preferential administration of antihypertensive combination therapy. Pharmacotherapeutic features of starting the treatment with a combination of angiotensin-converting enzyme inhibitors (ACEI) and calcium antagonists (AC) are reviewed. The authors also present the latest evidence on the ACEI/AC combination effects on such vascular parameters as microcirculation and endothelial dysfunction.
topic arterial hypertension
antihypertensive combination therapy
calcium antagonists
angiotensin-converting enzyme inhibitors
microcirculation
endothelial dysfunction
url https://cardiovascular.elpub.ru/jour/article/view/12
work_keys_str_mv AT llkirichenko anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT svgatsura anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT angolosova anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT kvovsyannikov anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT ovbudik anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT avfedorov anangiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT llkirichenko angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT svgatsura angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT angolosova angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT kvovsyannikov angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT ovbudik angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
AT avfedorov angiotensinconvertingenzymeinhibitorandcalciumantagonistcombinationinpharmacotherapyofarterialhypertension
_version_ 1721271034746765312